SolicitationPosted Jul 20, 2026·Responses due Jul 27, 2026

Periodic Health Assessment (PHA) Modernization Capability ISO PARATUS AOI 1

Defense Health Agency · DEFENSE HEALTH AGENCY

Stage
Open solicitation
NAICS
541512
Value
Not stated
Solicitation
HT003826SC004AOI1
Set-aside
None stated
PSC
DA01
Place
Rosslyn, VA, USA
Contact
Elizabeth M. Ruckwardt (elizabeth.m.ruckwardt.civ@health.mil)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT003826SC004AOI1 in this department, oldest first.

Early notice
None posted
Solicitation
  • Jul 20, 2026 · this notice
    Solicitation
  • Jul 20, 2026
    Solicitation
    Open
  • Jul 23, 2026
    Solicitation
    Open
Award
Not yet. Typical award: Aug 11, 2026 to Sep 29, 2026, middle of the range Aug 26, 2026.
Measured from 63 past solicitations at Defense Health Agency (Dha) that later posted an award (middle half of cases, counted from Jul 20, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

This Area of Interest (AOI) solicits innovative commercial solutions, or new applications of existing commercial technology, to close a defined capability gap in the Periodic Health Assessment (PHA) process governed by DOWI 6200.06 (Periodic Health Assessment Program) and DOWI 6025.19 (Individual Medical Readiness). This AOI does not constitute a Statement of Work or Performance Work Statement. It describes the Government's area of interest and the technical data and evaluation factors that will govern proposal selection. Offerors retain latitude to propose the technical approach, architecture… (show all)

, and implementation method that best satisfies the stated capability need, including proposing as part of a team consistent with Section 4.6. Following successful completion of Phase 2 (CDP Conformance Gate), the Government may, in its discretion, award a prototype Other Transaction agreement under 10 U.S.C. � 4022 to one or more offerors or teams who have passed Phase 2, using the competitive procedures conducted under this CSO through Phase 2 to satisfy the competitive-procedures prerequisite of 10 U.S.C. � 4022. Award of an OT agreement under this provision does not constitute completion of this AOI's technical evaluation; Phases 3 through 6 continue as post-award milestones under that agreement, administered per Section 4.9.Upon an offeror's or team's successful completion of Phase 6, whether reached through the standard AOI down-select described at Sections 4.7 and 4.8 or through post-award milestones under a prototype OT agreement awarded under Section 4.9, the Government may, in its discretion, either (a) extend or convert that offeror's or team's prototype OT agreement to a follow-on production agreement which may include a sole-source follow-on production contract under 10 U.S.C. � 4022 Nothing in this section commits the Government to any award, or alters the Government's discretion described at Section 6.

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same NAICS 541512.

Single-winner award sizes (3): middle half $3.6M to $7.5M, median $6.8M; range $283K to $8.1M.

WinnerAwardsValueLast
LEIDOS, INC. · $LDOS · $15.3B1$8.1MMay 8, 2026
A1Fed Incorporated1$6.8MJan 22, 2025
Abbott Rapid Diagnostics Informatics, Inc · $ABT · $40.1B1$283KAug 26, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $LDOS reported $15.3B revenue in FY2025. The median single-winner award in these 3 past awards, $6.8M, is under 0.1% of that. 10-K
  • $ABT reported $40.1B revenue in FY2025. The median single-winner award in these 3 past awards, $6.8M, is under 0.1% of that. 10-K

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 2 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (13 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • $365K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Armed Services, Senate Committee on Appropriations, Senate Committee on Armed Services
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 8 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 2 of the past winners are listed companies
  • 0 insider buys and 4 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.